These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
494 related articles for article (PubMed ID: 16468325)
41. [Detection of trisomy 8 with interphase fluorescence in situ hybridization in myelodysplastic syndromes]. Li J; Pan J; Xue Y; Wu C; Xie X; Guo Y; Ruan C Zhonghua Xue Ye Xue Za Zhi; 2000 Apr; 21(4):179-81. PubMed ID: 11876976 [TBL] [Abstract][Full Text] [Related]
42. Study of 30 patients with unexplained developmental delay and dysmorphic features or congenital abnormalities using conventional cytogenetics and multiplex FISH telomere (M-TEL) integrity assay. Popp S; Schulze B; Granzow M; Keller M; Holtgreve-Grez H; Schoell B; Brough M; Hager HD; Tariverdian G; Brown J; Kearney L; Jauch A Hum Genet; 2002 Jul; 111(1):31-9. PubMed ID: 12136233 [TBL] [Abstract][Full Text] [Related]
43. Karyotyping human chromosomes by combinatorial multi-fluor FISH. Speicher MR; Gwyn Ballard S; Ward DC Nat Genet; 1996 Apr; 12(4):368-75. PubMed ID: 8630489 [TBL] [Abstract][Full Text] [Related]
44. Hidden chromosome abnormalities in haematological malignancies detected by multicolour spectral karyotyping. Veldman T; Vignon C; Schröck E; Rowley JD; Ried T Nat Genet; 1997 Apr; 15(4):406-10. PubMed ID: 9090389 [TBL] [Abstract][Full Text] [Related]
45. [Molecular cytogenetic analysis of -7/7q- abnormalities in patients with myeloid malignancies]. Xiao Y; Liu SH; Liu XP; Qin S; Bo LJ; Li CW; Dai Y; Wang JS Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Dec; 20(6):471-6. PubMed ID: 14669212 [TBL] [Abstract][Full Text] [Related]
46. [Dual-color FISH study on myelodysplastic syndrome with 1;7 translocation]. Shen Y; Xue Y; Li J; Pan J; Wu Y; Guo Y; Lu D Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Aug; 19(4):313-6. PubMed ID: 12170469 [TBL] [Abstract][Full Text] [Related]
47. Conventional and molecular cytogenetic findings of myelodysplastic syndrome patients. Yilmaz Z; Sahin FI; Kizilkilic E; Karakus S; Boga C; Ozdogu H Clin Exp Med; 2005 Jul; 5(2):55-9. PubMed ID: 16096854 [TBL] [Abstract][Full Text] [Related]
48. FISH analysis in addition to G-band karyotyping: utility in evaluation of myelodysplastic syndromes? Yang W; Stotler B; Sevilla DW; Emmons FN; Murty VV; Alobeid B; Bhagat G Leuk Res; 2010 Apr; 34(4):420-5. PubMed ID: 19800120 [TBL] [Abstract][Full Text] [Related]
49. Usefulness of cytogenetics in leukemias. VinSheth FJ; Sheth JJ; Patel AI; Shah AD; Verhest A Indian J Cancer; 2002; 39(4):139-42. PubMed ID: 12928572 [TBL] [Abstract][Full Text] [Related]
50. [Detection of monosomy 7 or 7q- in cases of myelodysplastic syndrome]. Shen Y; Xue Y; Li J; Guo Y; Pan J; Wu Y Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2001 Aug; 18(4):255-8. PubMed ID: 11484160 [TBL] [Abstract][Full Text] [Related]
51. Redefining monosomy 5 by molecular cytogenetics in 23 patients with MDS/AML. Herry A; Douet-Guilbert N; Morel F; Le Bris MJ; De Braekeleer M Eur J Haematol; 2007 Jun; 78(6):457-67. PubMed ID: 17391336 [TBL] [Abstract][Full Text] [Related]
52. [The application of fluorescence in situ hybridization in detecting chronic myeloid leukemia]. Qiu HR; Miao KR; Wang R; Qiao C; Zhang JF; Zhang SJ; Qian SX; Xu W; Li JY Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2009 Apr; 26(2):207-10. PubMed ID: 19350518 [TBL] [Abstract][Full Text] [Related]
53. Conventional cytogenetics and fluorescence in situ hybridization in persistent cytopenias and myelodysplastic syndromes in childhood. Touliatou V; Kolialexi A; Tsangaris GT; Moschovi M; Polychronopoulou S; Mavrou A Anticancer Res; 2004; 24(6):3945-9. PubMed ID: 15736436 [TBL] [Abstract][Full Text] [Related]
54. [Analysis the clinic and cytogenetics of myelodysplastic syndrome]. Cen L; Zhou M; Zhao YH Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Dec; 23(6):668-9. PubMed ID: 17160950 [TBL] [Abstract][Full Text] [Related]
55. Chromosomal cryptic insertion of the terminal region and its formative mechanism determined by fluorescence in situ hybridization. Tan Y; Lu G Chin Med J (Engl); 2002 Jul; 115(7):1039-42. PubMed ID: 12150739 [TBL] [Abstract][Full Text] [Related]
56. Do we need to do fluorescence in situ hybridization analysis in myelodysplastic syndromes as often as we do? Costa D; Valera S; Carrió A; Arias A; Muñoz C; Rozman M; Belkaid M; Coutinho R; Nomdedeu B; Campo E Leuk Res; 2010 Nov; 34(11):1437-41. PubMed ID: 20226525 [TBL] [Abstract][Full Text] [Related]
57. [A comparative study of fluorescence in situ hybridization versus conventional cytogenetics in the detection of clonal aberrations in myelodysplastic syndrome]. Lai YY; Li N; Feng L; Shi Y; Dang H; He Q; Wang Z; Wang XY; Li Y; Liu Q; Huang XJ Zhonghua Yi Xue Za Zhi; 2013 Oct; 93(40):3175-9. PubMed ID: 24405535 [TBL] [Abstract][Full Text] [Related]
58. Distinct cytogenetic pathways of advanced-stage neuroblastoma tumors, detected by spectral karyotyping. Stark B; Jeison M; Bar-Am I; Glaser-Gabay L; Mardoukh J; Luria D; Feinmesser M; Goshen Y; Stein J; Abramov A; Zaizov R; Yaniv I Genes Chromosomes Cancer; 2002 Jul; 34(3):313-24. PubMed ID: 12007192 [TBL] [Abstract][Full Text] [Related]
59. Unique cytogenetic features of primary myelodysplastic syndromes in Chinese patients. Li L; Liu XP; Nie L; Yu MH; Zhang Y; Qin TJ; Xiao ZJ Leuk Res; 2009 Sep; 33(9):1194-8. PubMed ID: 19128829 [TBL] [Abstract][Full Text] [Related]